Literature DB >> 15996008

Proteomic signatures for histological types of lung cancer.

Masahiro Seike1, Tadashi Kondo, Kazuyasu Fujii, Tetsuya Okano, Tesshi Yamada, Yoshihiro Matsuno, Akihiko Gemma, Shoji Kudoh, Setsuo Hirohashi.   

Abstract

We performed proteomic studies on lung cancer cells to elucidate the mechanisms that determine histological phenotype. Thirty lung cancer cell lines with three different histological backgrounds (squamous cell carcinoma, small cell lung carcinoma and adenocarcinoma) were subjected to two-dimensional difference gel electrophoresis (2-D DIGE) and grouped by multivariate analyses on the basis of their protein expression profiles. 2-D DIGE achieves more accurate quantification of protein expression by using highly sensitive fluorescence dyes to label the cysteine residues of proteins prior to two-dimensional polyacrylamide gel electrophoresis. We found that hierarchical clustering analysis and principal component analysis divided the cell lines according to their original histology. Spot ranking analysis using a support vector machine algorithm and unsupervised classification methods identified 32 protein spots essential for the classification. The proteins corresponding to the spots were identified by mass spectrometry. Next, lung cancer cells isolated from tumor tissue by laser microdissection were classified on the basis of the expression pattern of these 32 protein spots. Based on the expression profile of the 32 spots, the isolated cancer cells were categorized into three histological groups: the squamous cell carcinoma group, the adenocarcinoma group, and a group of carcinomas with other histological types. In conclusion, our results demonstrate the utility of quantitative proteomic analysis for molecular diagnosis and classification of lung cancer cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15996008     DOI: 10.1002/pmic.200401166

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  9 in total

1.  Identification of isocitrate dehydrogenase 1 as a potential diagnostic and prognostic biomarker for non-small cell lung cancer by proteomic analysis.

Authors:  Fengwei Tan; Ying Jiang; Nan Sun; Zhaoli Chen; Yongzhuang Lv; Kang Shao; Ning Li; Bin Qiu; Yibo Gao; Baozhong Li; Xiaogang Tan; Fang Zhou; Zhen Wang; Dapeng Ding; Jiwen Wang; Jian Sun; Jie Hang; Susheng Shi; Xiaoli Feng; Fuchu He; Jie He
Journal:  Mol Cell Proteomics       Date:  2011-11-07       Impact factor: 5.911

2.  Two-dimensional fluorescence difference gel electrophoresis for comparative proteomics profiling.

Authors:  Nilesh S Tannu; Scott E Hemby
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

3.  Down-regulation of 14-3-3 isoforms and annexin A5 proteins in lung adenocarcinoma induced by the tobacco-specific nitrosamine NNK in the A/J mouse revealed by proteomic analysis.

Authors:  James D Bortner; Arunangshu Das; Todd M Umstead; Williard M Freeman; Richard Somiari; Cesar Aliaga; David S Phelps; Karam El-Bayoumy
Journal:  J Proteome Res       Date:  2009-08       Impact factor: 4.466

Review 4.  Proteomic analysis in cancer research: potential application in clinical use.

Authors:  Jesús García-Foncillas; Eva Bandrés; Ruth Zárate; Natalia Remírez
Journal:  Clin Transl Oncol       Date:  2006-04       Impact factor: 3.405

5.  Histology image analysis for carcinoma detection and grading.

Authors:  Lei He; L Rodney Long; Sameer Antani; George R Thoma
Journal:  Comput Methods Programs Biomed       Date:  2012-03-20       Impact factor: 5.428

6.  Discovery of new membrane-associated proteins overexpressed in small-cell lung cancer.

Authors:  Sebahat Ocak; David B Friedman; Heidi Chen; Jamie A Ausborn; Mohamed Hassanein; Bruno Detry; Birgit Weynand; Frank Aboubakar; Charles Pilette; Yves Sibille; Pierre P Massion
Journal:  J Thorac Oncol       Date:  2014-03       Impact factor: 15.609

7.  Identification of haptoglobin peptide as a novel serum biomarker for lung squamous cell carcinoma by serum proteome and peptidome profiling.

Authors:  Tetsuya Okano; Masahiro Seike; Hidehiko Kuribayashi; Chie Soeno; Takeo Ishii; Kozui Kida; Akihiko Gemma
Journal:  Int J Oncol       Date:  2016-01-11       Impact factor: 5.650

Review 8.  [Research Progress of Biomakers Proteomics-based in Lung Cancer].

Authors:  Hui Xie; Zhengang Chen; Guangshun Wang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2015-06

9.  Identification of protein changes in the blood plasma of lung cancer patients subjected to chemotherapy using a 2D-DIGE approach.

Authors:  Andrzej Ciereszko; Mariola A Dietrich; Mariola Słowińska; Joanna Nynca; Michał Ciborowski; Joanna Kisluk; Anna Michalska-Falkowska; Joanna Reszec; Ewa Sierko; Jacek Nikliński
Journal:  PLoS One       Date:  2019-10-17       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.